Black Diamond Therapeutics (BDTX) Surges 115.9% YTD
Black Diamond Therapeutics (NASDAQ:BDTX) is a precision-oncology biotechnology company built on the idea that cancers driven by genetically…
Rhythm Pharma (RYTM) Surges as FDA Extends Review for IMCIVREE
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) is a biopharmaceutical company founded with a singular scientific focus: developing transformative therapies for…
Nuvalent (NUVL) Soars 16% After ALKOVE-1 Trial Shows 86% Response in TKI-Naïve Lung Cancer Patients
Nuvalent, Inc. (NASDAQ:NUVL) is a clinical-stage biotechnology company founded on the vision of designing precisely targeted therapies for…
Cypherpunk Technologies (CYPH) Skyrockets 284% in One Week After $58.9M Crypto Pivot
Cypherpunk Technologies (NASDAQ:CYPH) is a newly transformed digital-asset company that emerged from the rebranding of Leap Therapeutics, marking…
Cytek Bio (CTKB) Surges 39% in 1 Month After TIME 2026 Recognition
Cytek Biosciences Inc. (NASDAQ:CTKB) is a leading life-sciences technology company specializing in advanced cell analysis, driven by its…
Why Indaptus (INDP) Could Be a Sleeper Biotech Winner After $2.3M Financing Boost and Phase 1 Progress
Indaptus Therapeutics Inc. (NASDAQ:INDP) is a clinical-stage biotechnology company built around a bold scientific premise: that the next…
Is Apimeds (APUS) the Most Undervalued Small-Cap Biotech?
Apimeds Pharmaceuticals US Inc. (NYSE:APUS) is a clinical-stage biopharmaceutical company built on a mission to transform pain management…
DiaMedica (DMAC) Advances Preeclampsia Trial as Cash Runway Extends to 2027
DiaMedica Therapeutics Inc. (NASDAQ:DMAC) is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for serious diseases driven…
YD Bio (YDES) Surges After $13.2M Financing
YD Bio Limited (NASDAQ:YDES) is a biotechnology company built on a dual scientific foundation: advancing DNA methylation–based cancer…
Why Analysts Believe Oscar Health (OSCR) Could Become a $12B-Plus Digital Insurance Powerhouse
Oscar Health Inc. (NASDAQ:OSCR) is a technology-driven health insurance company founded with the mission of making healthcare simple,…
Twist Bioscience (TWST) Cash Position Hits $232.4M—Is It Enough to Fund 2026 Expansion?
Twist Bioscience (NASDAQ:TWST) is a synthetic biology and biotechnology company built on the vision of transforming how DNA…
Anavex (AVXL) Faces Major Setback as CHMP Issues Negative Vote on Alzheimer’s Drug
Anavex Life Sciences Corp. (NASDAQ:AVXL) is a clinical-stage biopharmaceutical company dedicated to developing novel therapeutics for central nervous…
Kura Oncology (KURA) Skyrockets After FDA Approves KOMZIFTI for NPM1-Mutated AML
Kura Oncology (NASDAQ:KURA) is a clinical-stage biopharmaceutical company built on the vision of developing precision medicines that target…
Korro Bio (KRRO) Surges After Human RNA Editing Success in AATD Trial
Korro Bio Inc. (NASDAQ:KRRO) is a clinical-stage biopharmaceutical company pioneering a new generation of genetic medicines through precise,…
Mersana Therapeutics (MRSN) Surges After $285M Acquisition Deal With Day One Biopharmaceuticals
Mersana Therapeutics (NASDAQ:MRSN) is a clinical-stage biopharmaceutical company shaped by a long-standing commitment to expanding what is possible…
Cidara Therapeutics (CDTX) Skyrockets 108.9% as Merck Acquisition Hits $221.50 Per Share
Cidara Therapeutics (NASDAQ:CDTX) is a clinical-stage biotechnology company founded with the mission of transforming the prevention and treatment…
Trevi Therapeutics (TRVI) Surges as Cash Runway Extends to 2028 After Reporting $194.9M Assets
Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for some of the most…
Greenwich LifeSciences (GLSI) Reports 100% Survival Data and Heavy Insider Buying!
Greenwich LifeSciences Inc. (NASDAQ:GLSI) is a clinical-stage biopharmaceutical company committed to developing innovative immunotherapy solutions for one of…